MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Heat Map Visualization of Improved Best ON Time in People With Parkinson’s Disease Treated With Foscarbidopa/Foslevodopa

    T. Henriksen, R. Hauser, I. Malaty, T. Kimber, M. Soileau, L. Bergmann, L. Harmer, J. Homola, R. Gupta, C. Yan, B. Bergmans (North Chicago, USA)

    Objective: Assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on the motor states of people with Parkinson’s disease (PD) across 24 hours via…
  • 2025 International Congress

    Phase I randomized, double-blind study to evaluate feasibility, safety, and clinical responses of implanting autologous peripheral nerve tissue into the nucleus basalis of Meynert or substantia nigra for non-motor or motor symptoms in patients with Parkinson’s disease undergoing DBS surgery (STAR) Trial

    J. Quintero, J. Slevin, J. Hixson, G. Gerhardt, C. van Horne (Lexington, USA)

    Objective: To evaluate the feasibility, safety, and clinical responses of bilateral delivery, at the time of deep brain stimulation (DBS) surgery, of autologous peripheral nerve…
  • 2025 International Congress

    Honey products in Parkinson’s disease – randomized placebo-controlled double-blind pilot study

    T. Endo, K. Toyooka, T. Matsumura, C. Mori, T. Saito, T. Saito, S. Sakoda (Toyonaka, Japan)

    Objective: The purpose of this study is to examine whether consumption of honey products can improve symptoms and their diurnal fluctuations in patients with Parkinson's…
  • 2025 International Congress

    Effect of Opicapone on Sleep-Related Complaints and Non-Motor Burden in Parkinson’s Patients: A Post-Hoc Analysis of the OASIS Trial

    J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, D. Martins, J. Holenz, C. Trenkwalder (Lisbon, Portugal)

    Objective: To assess the effect of opicapone (OPC) on different sleep complaints and non-motor symptoms (NMS) in fluctuating Parkinson’s disease (PD) patients with sleep disturbances.…
  • 2025 International Congress

    Trends on recruitment and retention in Parkinson’s Disease modification trials

    D. Hengartner, R. Palacio, J. Garinger, A. Lysandropoulos (Durham, USA)

    Objective: To identify the most common causes of participant’s screen failure (SF) and drop-out (DO) in Phase 2 and 3 Disease Modification Therapy (DMT) trials…
  • 2025 International Congress

    A Randomized Clinical Trial of Immersive Virtual Reality and Cognitive Rehabilitation for Mild Cognitive Impairment in Parkinson’s Disease

    A. Puig-Davi, A. Moreu-Valls, S. Martinez-Horta, G. Kulisevsky, J. Rodriguez-Antiguedad, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To investigate the efficacy of Immersive Virtual Reality (IVR) and Computerized Cognitive Training (CCT) for mild cognitive impairment in Parkinson’s disease (PD-MCI) Background: PD-MCI…
  • 2025 International Congress

    Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence

    R. Dolhun, D. Kumbroch, K. Klapper, K. Wu, L. Holding, K. Callahan (New York, USA)

    Objective: Create a survey-ready community of U.S.-based clinicians to share care-focused inputs that inform The Michael J. Fox Foundation’s (MJFF) research funding and recruitment, policy,…
  • 2025 International Congress

    Lighting the Torch: Dating the Most Common Recent Ancestor of the PINK1 p.L347P Variant Linked to Parkinson’s Disease in Pacific Populations

    C. Buchanan, A H. Tan, A. Ahmad-Annuar, S-Y. Lim, YW. Tay, T. Siddique, J. Donnelly, G. Monahan, M. Bruno, R. Minster, S. Viali, F. Fa'Alau, C. Puli'Uvea, N. Edwards, G. Vailahi, R. Roxburgh (Auckland, New Zealand)

    Objective: To determine the generational age of the most recent common ancestor (MRCA) of patients homozygous for PINK1 p.L347P, to 1) Test the hypothesis that…
  • 2025 International Congress

    Online Learning Preferences of Healthcare Providers Caring for People with Parkinson’s Disease

    A. Smiley, I. Blackwood, L. Hoffman, R. Miller, K. Fitzgerald, C. Gadala-Maria, E. Pollard, A. Paul (Miami, USA)

    Objective: This study aimed to identify the instructional preferences and barriers to continuing education (CE) participation and completion among healthcare professionals caring for people with…
  • 2025 International Congress

    Deciphering differences in Functional Movement Disorders between Children and Adults

    D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)

    Objective: To compare the characteristics of FMDs in children and adults Background: Functional movement disorders (FMDs) exhibit notable differences in phenomenology and treatment responses between…
  • « Previous Page
  • 1
  • …
  • 268
  • 269
  • 270
  • 271
  • 272
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley